Brief: Cipher Pharmaceuticals Reports Q2 EPS Of $0.07 From Continuing Operations
10/08/2018 12:31
Aug 10 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS REPORTS Q2 2018 RESULTS
* Q2 EARNINGS PER SHARE $0.07 FROM CONTINUING OPERATIONS
* Q2 REVENUE $7.0 MILLION VERSUS $9.9 MILLION
* EXPECTS ITS LICENSING BUSINESS TO PROVIDE A SOLID BASE OF
HIGH-MARGIN ROYALTY REVENUE IN 2018
Source text for Eikon: ID:nCNWjLS3Na
Further company coverage: CPH.TO
(Reuters.Briefs@thomsonreuters.com)
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million